These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17940373)

  • 1. [The fourth report from Sapporo Tsukisamu Hospital - chemotherapy and its regimen as second choice for patients with early gastric cancer].
    Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Yamaguchi K; Shirasaka T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1589-94. PubMed ID: 17940373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The third report from Sapporo Tsukisamu Hospital--chemotherapy for patients with advanced gastric cancer (peritoneal dissemination, peritonitis carcinomatosa)].
    Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Yamaguchi K; Shirasaka T
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1405-11. PubMed ID: 17876138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The first report from Sapporo Tsukisamu Hospital--chemotherapy and chemoradiotherapy for patients with advanced pancreatic cancer].
    Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Koito K; Shirasaka T
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1059-66. PubMed ID: 17637542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy of gastric cancer with oral UFT (a mixture of uracil and fturafur) during the waiting period for surgery.
    Nio Y; Sato Y; Nagami H; Teramoto M; Inoue Y; Yano S; Sumi S; Tamura K; Fukumoto M
    Anticancer Res; 1998; 18(1B):523-30. PubMed ID: 9568172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The second report from Sapporo Tsukisamu hospital--chemotherapy for patients with advanced colorectal cancer].
    Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Shirasaka T
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1241-7. PubMed ID: 17687205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modified pharmacokinetic modulating chemotherapy for progressive gastric cancer accompanied by peritoneal dissemination].
    Ishikawa T; Mizuno K; Togashi T; Watanabe K; Seki K; Ohta H; Yoshida T; Kamimura T
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):469-72. PubMed ID: 15853212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological characteristics of gastric cancer in elderly patients].
    Boku N; Okamoto R; Kandabashi K; Sasaki E; Omuro Y; Maeda Y; Sasaki T
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1099-103. PubMed ID: 16912528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [UFTPM (UFT + CDDP + MMC) therapy for progressive stomach cancer. Research Association of Progressive Stomach Cancer].
    Iwazaki R; Yasutake K; Fukuyama Y; Hasegawa K; Koizumi W; Sasai T; Kurihara M; Kubo Y; Ishikawa K; Hayakawa M
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1179-85. PubMed ID: 8333746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
    Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PMC (pharmacokinetic modulating chemotherapy) for advanced gastric cancer].
    Fujiwara Y; Kusunoki M; Nakagawa K; Nakao K; Itoh R; Yamamura T
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2175-81. PubMed ID: 10635301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of patients with locally advanced gastric cancer undergoing gastrectomy after pre-operative chemotherapy including S-1].
    Kinouchi M; Shibata C; Miura K; Okabe M; Andou T; Kakyou M; Saijou F; Haneda S; Ogawa H; Unno M; Sasaki I
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1481-4. PubMed ID: 19755816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients.
    Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Satake K; Taguchi T; Takahashi M; Kawakami M; Hanamura H; Watanabe M; Utsumi A
    Auris Nasus Larynx; 2009 Oct; 36(5):547-54. PubMed ID: 19097833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
    Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin.
    Boku N; Ohtsu A; Yoshida S; Shirao K; Shimada Y; Hyodo I; Saito H; Miyata Y;
    Jpn J Clin Oncol; 2007 Apr; 37(4):275-81. PubMed ID: 17522103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of low-dose FP therapy as adjuvant therapy for gastric cancer].
    Maeda Y; Sato Y; Yamamoto M; Shomura H; Honnma S; Kohashi S; Shinohara T; Takahashi S; Kondo M; Todo S
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):381-4. PubMed ID: 15791822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of the histoculture drug-response assay to contribute to cancer patient survival.
    Kubota T; Sasano N; Abe O; Nakao I; Kawamura E; Saito T; Endo M; Kimura K; Demura H; Sasano H
    Clin Cancer Res; 1995 Dec; 1(12):1537-43. PubMed ID: 9815954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.